20 years of Cure Parkinson's
We’re here for the cure! This year marks 20 years since Cure Parkinson’s was founded by four people living with Parkinson’s who felt that nobody was taking a cure seriously enough and that there was an urgent need for a focused approach to curative research...
Learn more
2021 Grouse & Grape Luncheon raises over £14k for Parkinson’s research
On Tuesday 7 December, over 90 guests attended the historic Cavalry and Guards Club on London’s Piccadilly for the annual Grouse & Grape Luncheon, raising over xx for Parkinson’s research.
Tackling toxic alpha-synuclein
Three major lines of clinical investigation are currently underway to determine if stopping the clustering of alpha-synuclein in Parkinson’s can help to slow down the progression of the disease.
ADepTing to the UCB-Novartis deal
Alpha synuclein has long been viewed at “Public enemy #1” by the Parkinson’s research community. This sticky, abundant protein starts to cluster (or aggregate) in Parkinson’s. There have been several attempts to reduce levels of the protein floating around outside of cells (using “immunotherapy” approaches) But now clinical research is ramping […]
Sisters fundraise and raise awareness for Cure Parkinson’s
Sisters Susanna and Eliza Kidd had a super summer of fundraising for Cure Parkinson’s!
The AND-PD Trial
This study (ANxiety with or without depressive features in Parkinson’s Disease ‘AND-PD’) is an observational and imaging study where people at different stages of Parkinson’s will be assessed and followed for one year. This study, led by Professor Anette Schrag, is looking to recruit around…